Literature DB >> 16103583

Comparison of IgG reactivities to Plasmodium vivax merozoite invasion antigens in a Brazilian Amazon population.

Tuan M Tran1, Joseli Oliveira-Ferreira, Alberto Moreno, Fatima Santos, Syed S Yazdani, Chetan E Chitnis, John D Altman, Esmeralda V-S Meyer, John W Barnwell, Mary R Galinski.   

Abstract

Naturally acquired antibody reactivity to two major Plasmodium vivax vaccine candidates was investigated in 294 donors from three malaria-endemic communities of Rondônia state, Brazil. Antibody recognition of recombinantly expressed antigens covering five different regions of P. vivax reticulocyte binding protein 1 (PvRBP1) and region II of P. vivax Duffy binding protein (PvDBP-RII) were compared. Positive IgG responses to these antigens were significantly related to the level of malaria exposure in terms of past infections and years of residence in the endemic area when corrected for age. The highest prevalence of anti-PvRBP1 total IgG antibodies corresponded to the amino acid regions denoted PvRBP1(431-748) (41%) and PvRBP1(733-1407) (47%). Approximately one-fifth of positively responding sera had titers of at least 1:1,600. Total IgG responses to PvDBP-RII were more prevalent (67%), of greater magnitude, and acquired more rapidly than those to individual PvRBP1 antigens. Responses to both PvRBP1 and PvDBP-RII were biased toward the cytophilic subclasses IgG1 and IgG3. These data provide the first insights on acquired antibody responses to PvRBP1 and a comparative view with PvDBP-RII that may prove valuable for understanding protective immune responses to these two vaccine candidates as they are evaluated as components of multitarget blood-stage vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103583

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  37 in total

1.  Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.

Authors:  Sédami Gnidehou; Catherine J Mitran; Eliana Arango; Shanna Banman; Angie Mena; Evelyn Medawar; Barbara A S Lima; Justin Doritchamou; Jahanara Rajwani; Albert Jin; Kenneth Gavina; Francis Ntumngia; Patrick Duffy; David Narum; Nicaise Tuikue Ndam; Morten A Nielsen; Ali Salanti; Flora S Kano; Luzia H Carvalho; John H Adams; Amanda Maestre; Michael F Good; Stephanie K Yanow
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

2.  Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.

Authors:  Jennifer L Cole-Tobian; Pascal Michon; Moses Biasor; Jack S Richards; James G Beeson; Ivo Mueller; Christopher L King
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

3.  Malaria in Brazil: an overview.

Authors:  Joseli Oliveira-Ferreira; Marcus V G Lacerda; Patrícia Brasil; José L B Ladislau; Pedro L Tauil; Cláudio Tadeu Daniel-Ribeiro
Journal:  Malar J       Date:  2010-04-30       Impact factor: 2.979

4.  Naturally Acquired Human Antibodies Against Reticulocyte-Binding Domains of Plasmodium vivax Proteins, PvRBP2c and PvRBP1a, Exhibit Binding-Inhibitory Activity.

Authors:  Enna Dogra Gupta; Gaurav Anand; Hina Singh; Kritika Chaddha; Praveen K Bharti; Neeru Singh; Yagya Dutta Sharma; Deepak Gaur
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

5.  B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.

Authors:  J C Lima-Junior; J Jiang; R N Rodrigues-da-Silva; D M Banic; T M Tran; R Y Ribeiro; V S E Meyer; S G De-Simone; F Santos; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

6.  Duffy Blood Group System and the malaria adaptation process in humans.

Authors:  Gledson Barbosa de Carvalho; Glauber Barbosa de Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2011

7.  Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.

Authors:  A Moreno; I Caro-Aguilar; S S Yazdani; A R Shakri; S Lapp; E Strobert; H McClure; C E Chitnis; M R Galinski
Journal:  Vaccine       Date:  2008-06-23       Impact factor: 3.641

8.  Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.

Authors:  J C Lima-Junior; T M Tran; E V S Meyer; B Singh; S G De-Simone; F Santos; C T Daniel-Ribeiro; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 9.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

10.  Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.

Authors:  Carmen Fernandez-Becerra; Sergi Sanz; Marina Brucet; Danielle I Stanisic; Fabiana P Alves; Erney P Camargo; Pedro L Alonso; Ivo Mueller; Hernando A del Portillo
Journal:  Malar J       Date:  2010-01-21       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.